Residual estrogen receptor availability during fulvestrant 500 mg therapy in patients with metastatic breast cancer.

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Number of pages1
JournalJournal of Clinical Oncology
Volume32
Issue number15
Publication statusPublished - 20-May-2014
Event50th Annual Meeting of the American-Society-of-Clinical-Oncology - Chicago, United States
Duration: 30-May-20143-Jun-2014

Cite this